Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Replicative Cell Senescence02:15

Replicative Cell Senescence

4.5K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

38.7K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oncogenic Ras drives EED degradation and PRC2 dysfunction to promote aggressive squamous cell carcinoma.

Nature communications·2026
Same author

A dietary switch promotes sensory neuron-dependent cancer-associated cachexia.

Science (New York, N.Y.)·2026
Same author

MelOD: The Melanoma Omics Dashboard for Multimodal Data Exploration.

Pigment cell & melanoma research·2026
Same author

Autophagy Inhibition Reprograms the Tumor Microenvironment of Pancreatic Cancer to Promote Macrophage Phagocytosis of Tumor Cells.

Cancer research·2026
Same author

Lymphatic egress recycles tumor-experienced effector CD8 T cells to sustain immune surveillance.

bioRxiv : the preprint server for biology·2026
Same author

Dual inhibition of GTP-bound (ON) and GDP-bound (OFF) KRAS<sup>G12C</sup> suppresses PI3Kα and leads to potent tumor inhibition.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Feb 28, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

9.6K

PARP1 Suppression Drives ROS Resistance in Aneuploid Cancer Cells.

Pan Cheng1,2, Angela Mermerian-Baghdassarian1,2, Yufeng Wang1,2

  • 1Institute for Systems Genetics and Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, USA.

Biorxiv : the Preprint Server for Biology
|February 27, 2026
PubMed
Summary

Aneuploidy, or chromosome number variation, enhances cancer cell survival against oxidative stress by suppressing Poly(ADP-Ribose) Polymerase 1 (PARP1). This suppression promotes tumor metastasis, revealing a new link between aneuploidy and cancer progression.

More Related Videos

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

4.7K
Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
15:53

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

15.6K

Related Experiment Videos

Last Updated: Feb 28, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

9.6K
Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

4.7K
Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
15:53

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

15.6K

Area of Science:

  • Cancer Biology
  • Genetics
  • Cellular Stress Response

Background:

  • Aneuploidy, characterized by abnormal chromosome numbers, is common in cancer and linked to tumor progression.
  • The molecular mechanisms by which aneuploidy influences cancer remain largely unknown.
  • Aneuploidy's role in resistance to cell death pathways, particularly oxidative stress, requires further elucidation.

Purpose of the Study:

  • To investigate the functional consequences of aneuploidy on cancer cell survival and identify underlying molecular mechanisms.
  • To explore the link between aneuploidy, reactive oxygen species (ROS) resistance, and cancer metastasis.
  • To uncover novel regulators of aneuploidy-mediated phenotypes.

Main Methods:

  • Generation of novel aneuploid cell models.
  • Assessment of cell death resistance to ROS.
  • Poly(ADP-Ribose) Polymerase 1 (PARP1) expression and activity analysis.
  • Genome-wide CRISPR screening to identify genetic modifiers.
  • Validation in multiple cell lines and human tumor samples.

Main Results:

  • Aneuploidy confers significant resistance to ROS-mediated cell death, independent of specific chromosomal changes.
  • Aneuploid cells exhibit suppressed Poly(ADP-Ribose) Polymerase 1 (PARP1) expression and activity, inhibiting ROS-induced cell death (parthanatos).
  • CCAAT/enhancer-binding protein beta (CEBPB) was identified as a key transcription factor mediating PARP1 suppression and ROS resistance in aneuploid cells, activated by lysosomal dysfunction.
  • Decreased PARP1 levels promote tumor metastasis, while PARP1 restoration suppresses it.

Conclusions:

  • Aneuploidy promotes cancer cell survival and metastasis through the suppression of PARP1, mediated by CEBPB activation.
  • This pathway represents a novel mechanism linking aneuploidy to enhanced cancer progression and metastatic potential.
  • Targeting the aneuploidy-CEBPB-PARP1 axis may offer new therapeutic strategies for cancer treatment.